Description
Erlocip (Erlotinib) 150mg Online
Erlocip (Erlotinib) is known as a tyrosine kinase inhibitor and it treats cancer by disrupting the chemical process needed for cancer cell growth. Types of cancer for which it is used include metastatic NSCLC (non-small cell lung cancer), and for maintenance in cases of NSCLC which is said to be locally advanced or metastatic when the disease has shown no signs of progression after other forms of chemotherapy. In addition to this, it is also given alongside gemcitabine for the treatment of pancreatic cancer (either locally advanced, metastatic or unresectable).
The growth of the cancer cells is due to structures present on the surface of the cells called the EGFRs (an abbreviation for epidermal growth factor receptors). Their role is to help a type of protein called the EGF (epidermal growth factor) bind to their receptors and activate the tyrosine kinase enzyme. This is what causes the growth of the cancer cells.
By inhibiting the EGFR’s kinase action, this medicine helps to stop the growth process of the cells, resulting in the slowing down or cessation of cell growth.
Erlocip, manufactured by Cipla, contains “Erlotinib (Erlotinib 100 mg Tablet)” as an active ingredient. Erlotinib Hydrochloride Tablets is a tyrosine kinase inhibitor that comes under the strengths of 100 mg and 150 mg in each tablet. Erlocip tablet works by helping to stop cancer cells from growing. Erlotinib 100 mg tablet highly prescribed the drug for treating certain types of advanced or metastatic lung cancer. Erlotinib 100 is also used to treat certain types of pancreatic cancer in combination with other medications.
